Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Haematology|May 26, 2020
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studiesRégis Peffault de Latour, Robert A Brodsky, Stephan Ortiz, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2016
Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 studyJames Krueger, James D Clark, Mayte Suárez-Fariñas, et al.
Blood Advances|September 2, 2018
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studiesAlexander Röth, Scott T Rottinghaus, Anita Hill, et al.
Haematologica|January 18, 2020
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuriaRobert A Brodsky, Régis Peffault de Latour, Scott T Rottinghaus, et al.
Blood|December 5, 2018
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 studyAustin G Kulasekararaj, Anita Hill, Scott T Rottinghaus, et al.
Annals of Internal Medicine|January 20, 2015
Combination antifungal therapy for invasive aspergillosis: a randomized trialKieren A Marr, Haran T Schlamm, Raoul Herbrecht, et al.
Pageof 2